OssDsign Catalyst®
- Introduction
1. Nanotechnology and ionic amplification
– Nanoscale structure enables interaction with bone cells
– Silicate ions amplify the bone formation process
2. Dual bone formation pathways
– Most bone grafts engage the intramembranous pathway at the edges of the fusion
– Catalyst also engages the endochondral pathway at the center of the fusion
– Simultanous bone formation is observed at early time points
3. First class handling
– Available for immediate use
– Easy intra-operative manipulation
– Mixes well 1:1 with local autograft
– Packs well into an interbody cage
– Pushes easily down a canula
OssDsign Catalyst is now indicated for interbody fusion
– Now indicated for use with interbody cages cleared for use with a bone void filler.
– The first synthetic bone graft to be cleared to market for interbody use based on bone graft data alone, allowing on-label use in any interbody cage cleared for use with synthetic bone grafts.